MARS an improved de novo peptide candidate selection method for non-canonical antigen target discovery in cancer.

All five test sets yielded one-sided paired Wilcoxon signed-rank test p values < 2.2E10-16, indicating that the reduction of F-ranks by applying the (M + A) α model in comparison to the ALC baseline model was highly significant (Supplementary Table 1 , Fig. 1A, B ).

also in 132,142 other papers